Association of the IVS1 −27G/A polymorphism of Krüppel-like factor 6 (KLF6) with gastric cancer was examined in a Chinese population comprising 300 gastric cancer patients and 300 healthy controls. Single-nucleotide polymorphism analysis was performed by amplifying intron 1 of KLF6 and sequencing the products. The KLF6 genotype IVS1 −27AA was significantly less frequent in gastric cancer patients than in controls and significantly less frequent in patients with advanced (stage III/IV) gastric cancer than in those with early (stage I/II) cancer. Stratification by location, Lauren's classification and histological differentiation revealed no significant differences in genotype distribution. Thus, in this Chinese population the KLF6 IVS1 −27AA genotype was associated with a decreased risk of gastric cancer and with cancer stage. Further study is required to clarify the mechanisms involved and, potentially, to facilitate the design of effective clinical trials.
ParkinDMBrayFFerlayJ: Global cancer statistics, 2002. CA Cancer J Clin2005; 55: 74–108.
2.
ParkinDMBrayFFerlayJ: Estimating the world cancer burden: Globocan 2000. Int J Cancer2001; 94: 153–156.
3.
GonzálezCASalaNCapelláG: Genetic susceptibility and gastric cancer risk. Int J Cancer2002; 100: 249–260.
4.
ChenKFLiBWeiYG: Interleukin-10 −819 promoter polymorphism associated with gastric cancer among Asians. J Int Med Res2010; 38: 1–8.
5.
KimuraKNagasakaTHoshizimaN: No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations. J Int Med Res2007; 35: 450–457.
6.
BlackARBlackJDAzizkhan-CliffordJ: Sp1 and Krüppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol2001; 188: 143–160.
7.
DiFeoAMartignettiJANarlaG: The role of KLF6 and its splice variants in cancer therapy. Drug Resist Updat2009; 12: 1–7.
8.
GuoHLinYZhangH: Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol Biol2007; 8: 110.
9.
NarlaGHeathKEReevesHL: KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science2001; 294: 2563–2566.
10.
BiekerJJ: Krüppel-like factors: Three fingers in many pies. J Biol Chem2001; 276: 34355–34358.
11.
LiuJDuTYuanY: KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway. Mol Cell Biochem2010; 335: 29–35.
12.
DiFeoAHuangFSangodkarJ: KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model. Cancer Res2009; 69: 4733–4741.
13.
TaharaEKadaraHLacroixL: Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction. Cancer Biol Ther2009; 8: 801–807.
14.
ChenCHyytinenERSunX: Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol2003; 162: 1349–1354.
15.
Bar-ShiraAMatarassoNRosnerS: Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6. Prostate2006; 66: 1052–1060.
16.
SeppäläEHAutioVDuggalP: KLF6 IVS1 −27G>A variant and the risk of prostate cancer in Finland. Eur Urol2007; 52: 1076–1081.
17.
Kremer-TalSReevesHLNarlaG: Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology2004; 40: 1047–1052.
18.
ChoYGKimCJParkCH: Genetic alterations of the KLF6 gene in gastric cancer. Oncogene2005; 24: 4588–4590.
19.
ReevesHLNarlaGOgunbiyiO: Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology2004; 126: 1090–1103.
20.
SangodkarJShiJDiFeoA: Functional role of the KLF6 tumour suppressor gene in gastric cancer. Eur J Cancer2009; 45: 666–676.
21.
MiyakiMYamaguchiTIijimaT: Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients. Oncology2006; 71: 131–135.
22.
NarlaGFriedmanSLMartignettiJA: Krüppel cripples prostate cancer: KLF6 progress and prospects. Am J Pathol2003; 162: 1047–1052.
23.
SpinolaMLeoniVPGalvanA: Genome**ewide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett2007; 251: 311–316.
24.
AgellLHernándezSde MugaS: KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations. Mod Pathol2008; 21: 1470–1478.
25.
DiFeoANarlaGHirshfeldJ: Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res2006; 12: 3730–3739.
26.
NarlaGDiFeoAYaoS: Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res2005; 65: 5761–5768.
27.
NarlaGDiFeoAReevesHL: A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res2005; 65: 1213–1222.
28.
ChoYGLeeHSSongJH: KLF6 IVS1 −27G/A polymorphism with susceptibility to gastric cancers in Korean. Neoplasma2008; 55: 47–50.
29.
RaymondMRoussetF: GENEPOP (version 1.2): Population genetics software for exact tests and ecumenicism. J Hered1995; 86: 248–249.
30.
WangSKangLChenX: Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma. J Huazhong Univ Sci Technolog Med Sci2010; 30: 470–476.
31.
PanXCChenZChenF: Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas. J Zhejiang Univ Sci B2006; 7: 830–836.
32.
MieleLBealeGPatmanG: The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology2008; 135: 282–291.e1.
33.
HuangXLiXGuoB: KLF6 induces apoptosis in prostate cancer cells through up-regulation of ATF3. J Biol Chem2008; 283: 29795–29801.
34.
HartelMNarlaGWenteMN: Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Eur J Cancer2008; 44: 1895–1903.
35.
NarlaGDiFeoAFernandezY: KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. J Clin Invest2008; 118: 2711–2721.
